Skip to main content
Erschienen in:

26.11.2021 | Review Article

Association of Breast Surgeons of India (ABSI) Practical Consensus Statement, Recommendations, and Guidelines for the Treatment of Breast Cancer in India 2021—Indian Solutions for Indian Problems

verfasst von: S. P. Somashekhar, S. V. S. Deo, Diptendra Sarkar, K. R. Ashwin, C. Rohit Kumar, Navneet Kaur, Sanjay Jain, Raghuram Pillarisetti

Erschienen in: Indian Journal of Surgery | Sonderheft 3/2022

Einloggen, um Zugang zu erhalten

Abstract

Several international and national consensus guidelines from professional bodies and expert panels are available for the management of breast cancers. The widely used international guidelines are from the National Comprehensive Cancer Network (NCCN), St. Gallen International Expert Consensus, and the European Society of Medical Oncology (ESMO) and the National Institute for Health and Care Excellence (NICE) of the UK. This article is an update from the Association of Breast Surgeons of India (ABSI) regarding the guidelines to manage breast cancer in India. The earlier version of the same was published in 2016. This article has been updated with the latest research work in the management of breast cancer to date and necessary changes made to the earlier version.
Literatur
1.
Zurück zum Zitat Wild CP, Weiderpass E, Stewart BW, editors (2020) World Cancer Report: Cancer Research for Cancer Prevention. Lyon, France: International Agency for Research on Cancer. Available from: http://publications.iarc.fr/586 Wild CP, Weiderpass E, Stewart BW, editors (2020) World Cancer Report: Cancer Research for Cancer Prevention. Lyon, France: International Agency for Research on Cancer. Available from: http://​publications.​iarc.​fr/​586
5.
Zurück zum Zitat Jemal A, Bray F, Melissa MC, Jacques F, Elizabeth W, Forman D (2011) Global Cancer Statistics. CA Cancer J Clin 61:69–90CrossRefPubMed Jemal A, Bray F, Melissa MC, Jacques F, Elizabeth W, Forman D (2011) Global Cancer Statistics. CA Cancer J Clin 61:69–90CrossRefPubMed
8.
Zurück zum Zitat Mathur P, Sathishkumar K, Chaturvedi M, Das P, Sudarshan KL, Santhappan S, Nallasamy V, John A, Narasimhan S, Roselind FS, ICMR-NCDIR-NCRP Investigator Group. Cancer Statistics (2020) 2020: Report from National Cancer Registry Programme, India. JCO Glob Oncol 6:1063–1075. https://doi.org/10.1200/GO.20.00122CrossRefPubMed Mathur P, Sathishkumar K, Chaturvedi M, Das P, Sudarshan KL, Santhappan S, Nallasamy V, John A, Narasimhan S, Roselind FS, ICMR-NCDIR-NCRP Investigator Group. Cancer Statistics (2020) 2020: Report from National Cancer Registry Programme, India. JCO Glob Oncol 6:1063–1075. https://​doi.​org/​10.​1200/​GO.​20.​00122CrossRefPubMed
13.
Zurück zum Zitat Somsekhar SP, Geeta K, Jain R, Nayyer R, Halder S, Malik VK et al (2018) Practical consensus recommendations regarding role of mastectomy in metastatic breast cancer. South Asian J Cancer 7:79–82CrossRefPubMedPubMedCentral Somsekhar SP, Geeta K, Jain R, Nayyer R, Halder S, Malik VK et al (2018) Practical consensus recommendations regarding role of mastectomy in metastatic breast cancer. South Asian J Cancer 7:79–82CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Dey S (2014) Preventing breast cancer in LMICs via screening and/ or early detection: the real and the surreal. World J Clin Oncol 5(3):509–519CrossRefPubMedPubMedCentral Dey S (2014) Preventing breast cancer in LMICs via screening and/ or early detection: the real and the surreal. World J Clin Oncol 5(3):509–519CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Pillarisetti Raghu Ram (2020) “Perspective from India: improving breast health care” (Chapter 35) – “Breast Cancer: Global Quality Care”, edited by Didier Verhoeven, Cary Kaufman, Robert Mansel, Sabine Siesling. Oxford University Press, Oxford, pp 371–376 Pillarisetti Raghu Ram (2020) “Perspective from India: improving breast health care” (Chapter 35) – “Breast Cancer: Global Quality Care”, edited by Didier Verhoeven, Cary Kaufman, Robert Mansel, Sabine Siesling. Oxford University Press, Oxford, pp 371–376
17.
Zurück zum Zitat Tabar L, Fagerberg CJ, Gad A et al (1985) Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1:829–832 results in 549,091 women. Cancer 126:2971–2979 Tabar L, Fagerberg CJ, Gad A et al (1985) Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1:829–832 results in 549,091 women. Cancer 126:2971–2979
18.
Zurück zum Zitat Duffy SW, Smith RA, Tabár L, Dean PB, Chen TH (2019) The incidence of fatal breast cancer measures the increased effectiveness of therapy in women participating in mammography screening. Cancer 125(4):515–523CrossRefPubMed Duffy SW, Smith RA, Tabár L, Dean PB, Chen TH (2019) The incidence of fatal breast cancer measures the increased effectiveness of therapy in women participating in mammography screening. Cancer 125(4):515–523CrossRefPubMed
20.
Zurück zum Zitat Moss SM, Cuckle H, Evans A, Johns L, Waller M, Bobrow L (2006) Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years’ follow-up: a randomised controlled trial. Lancet 368:2053–2060CrossRefPubMed Moss SM, Cuckle H, Evans A, Johns L, Waller M, Bobrow L (2006) Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years’ follow-up: a randomised controlled trial. Lancet 368:2053–2060CrossRefPubMed
21.
Zurück zum Zitat Harford JB (2011) Breast-cancer early detection in low-income and middle income countries: do what you can versus one size fits all. Lancet Oncol 12:306–312CrossRefPubMed Harford JB (2011) Breast-cancer early detection in low-income and middle income countries: do what you can versus one size fits all. Lancet Oncol 12:306–312CrossRefPubMed
22.
Zurück zum Zitat Somashekhar SP, Kumar CR, Ashwin KR, Zaveri SS, Jampani A, Ramya Y, Parameswaran R, Rakshit S (2020) Can low-cost indo cyanine green florescence technique for sentinel lymph node biopsy replace dual dye (radio-colloid and blue dye) technique in early breast cancer: a prospective two-arm comparative study. Clin Breast Cancer 20(5):e576–e583. https://doi.org/10.1016/j.clbc.2020.03.013CrossRefPubMed Somashekhar SP, Kumar CR, Ashwin KR, Zaveri SS, Jampani A, Ramya Y, Parameswaran R, Rakshit S (2020) Can low-cost indo cyanine green florescence technique for sentinel lymph node biopsy replace dual dye (radio-colloid and blue dye) technique in early breast cancer: a prospective two-arm comparative study. Clin Breast Cancer 20(5):e576–e583. https://​doi.​org/​10.​1016/​j.​clbc.​2020.​03.​013CrossRefPubMed
23.
Zurück zum Zitat Chauhan A, Sharma MM (2016) Evaluation of surgical outcomes following oncoplastic breast surgery in early breast cancer and comparison with conventional breast conservation surgery. Med J Armed Forces India 72(1):12–18CrossRefPubMed Chauhan A, Sharma MM (2016) Evaluation of surgical outcomes following oncoplastic breast surgery in early breast cancer and comparison with conventional breast conservation surgery. Med J Armed Forces India 72(1):12–18CrossRefPubMed
24.
Zurück zum Zitat Deo SV, Samaiya A, Shukla NK, Mohanti BK, Raina V, Purkayastha J, Bhutani M, Kar M, Hazarika S, Rath GK (2005) Breast conservation therapy for breast cancer: patient profile and treatment outcome at a tertiary care cancer centre. Natl Med J India 18(4):178–81PubMed Deo SV, Samaiya A, Shukla NK, Mohanti BK, Raina V, Purkayastha J, Bhutani M, Kar M, Hazarika S, Rath GK (2005) Breast conservation therapy for breast cancer: patient profile and treatment outcome at a tertiary care cancer centre. Natl Med J India 18(4):178–81PubMed
26.
Zurück zum Zitat Rolph R, Mehta S, Farhadi J (2016) Breast reconstruction: options post-mastectomy. Br J Hosp Med (Lond) 77(6):334–342CrossRef Rolph R, Mehta S, Farhadi J (2016) Breast reconstruction: options post-mastectomy. Br J Hosp Med (Lond) 77(6):334–342CrossRef
27.
Zurück zum Zitat Guillem JG, Wood WC, Moley JF et al (2006) ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes. J Clin Oncol 24(28):4642–4660CrossRefPubMed Guillem JG, Wood WC, Moley JF et al (2006) ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes. J Clin Oncol 24(28):4642–4660CrossRefPubMed
28.
Zurück zum Zitat Malhotra H, Kowtal P, Mehra N, Pramank R, Sarin R, Rajkumar T, Gupta S, Bapna A, Bhattacharyya GS, Gupta S, Maheshwari A, Mannan AU, Reddy Kundur R, Sekhon R, Singhal M, Smruti BK, Sp S, Suryavanshi M, Verma A (2020) Genetic counseling, testing, and management of HBOC in India: an expert consensus document from Indian Society of Medical and Pediatric Oncology. JCO Glob Oncol 6:991–1008. https://doi.org/10.1200/JGO.19.00381CrossRefPubMed Malhotra H, Kowtal P, Mehra N, Pramank R, Sarin R, Rajkumar T, Gupta S, Bapna A, Bhattacharyya GS, Gupta S, Maheshwari A, Mannan AU, Reddy Kundur R, Sekhon R, Singhal M, Smruti BK, Sp S, Suryavanshi M, Verma A (2020) Genetic counseling, testing, and management of HBOC in India: an expert consensus document from Indian Society of Medical and Pediatric Oncology. JCO Glob Oncol 6:991–1008. https://​doi.​org/​10.​1200/​JGO.​19.​00381CrossRefPubMed
29.
Zurück zum Zitat Hartmann LC, Schaid DJ, Woods JE et al (1999) Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 340(2):77–84CrossRefPubMed Hartmann LC, Schaid DJ, Woods JE et al (1999) Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 340(2):77–84CrossRefPubMed
30.
Zurück zum Zitat Domchek SM, Friebel TM, Singer CF et al (2010) Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 304(9):967–975CrossRefPubMedPubMedCentral Domchek SM, Friebel TM, Singer CF et al (2010) Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 304(9):967–975CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Rebbeck TR, Friebel T, Lynch HT et al (2004) Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 22(6):1055–1062CrossRefPubMed Rebbeck TR, Friebel T, Lynch HT et al (2004) Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 22(6):1055–1062CrossRefPubMed
32.
Zurück zum Zitat Meijers-Heijboer H, van Geel B, van Putten WL et al (2001) Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 345(3):159–164CrossRefPubMed Meijers-Heijboer H, van Geel B, van Putten WL et al (2001) Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 345(3):159–164CrossRefPubMed
33.
Zurück zum Zitat Kadri MSN, Patel KM, Bhargava PA, Shah FD, Badgujar NV, Tarapara BV, Patel PS, Shaikh MI, Shah K, Patel A, Pandya S, Vora H, Joshi CG, Joshi MN (2021) Mutational landscape for Indian hereditary breast and ovarian cancer cohort suggests need for identifying population specific genes and biomarkers for screening. Front Oncol 21(10):568786. https://doi.org/10.3389/fonc.2020.568786CrossRef Kadri MSN, Patel KM, Bhargava PA, Shah FD, Badgujar NV, Tarapara BV, Patel PS, Shaikh MI, Shah K, Patel A, Pandya S, Vora H, Joshi CG, Joshi MN (2021) Mutational landscape for Indian hereditary breast and ovarian cancer cohort suggests need for identifying population specific genes and biomarkers for screening. Front Oncol 21(10):568786. https://​doi.​org/​10.​3389/​fonc.​2020.​568786CrossRef
35.
Zurück zum Zitat Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR, Winchester DP (2017) The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin 67(2):93–99. https://doi.org/10.3322/caac.21388CrossRefPubMed Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR, Winchester DP (2017) The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin 67(2):93–99. https://​doi.​org/​10.​3322/​caac.​21388CrossRefPubMed
37.
Zurück zum Zitat Early Breast Cancer Trialists’ Collaborative Group (1998) Tamoxifen for early breast cancer: an overview of the randomized trials. Lancet 351:1451–1467CrossRef Early Breast Cancer Trialists’ Collaborative Group (1998) Tamoxifen for early breast cancer: an overview of the randomized trials. Lancet 351:1451–1467CrossRef
38.
Zurück zum Zitat Fisher B, Costantino JP, Wickerham DL et al (1998) Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90:1371–1388CrossRefPubMed Fisher B, Costantino JP, Wickerham DL et al (1998) Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90:1371–1388CrossRefPubMed
40.
Zurück zum Zitat Sariego J, Zrada S, Byrd M et al (1995) Breast cancer in young patients. Am J Surg 170(3):243–245CrossRefPubMed Sariego J, Zrada S, Byrd M et al (1995) Breast cancer in young patients. Am J Surg 170(3):243–245CrossRefPubMed
Metadaten
Titel
Association of Breast Surgeons of India (ABSI) Practical Consensus Statement, Recommendations, and Guidelines for the Treatment of Breast Cancer in India 2021—Indian Solutions for Indian Problems
verfasst von
S. P. Somashekhar
S. V. S. Deo
Diptendra Sarkar
K. R. Ashwin
C. Rohit Kumar
Navneet Kaur
Sanjay Jain
Raghuram Pillarisetti
Publikationsdatum
26.11.2021
Verlag
Springer India
Erschienen in
Indian Journal of Surgery / Ausgabe Sonderheft 3/2022
Print ISSN: 0972-2068
Elektronische ISSN: 0973-9793
DOI
https://doi.org/10.1007/s12262-021-03160-y

Neu im Fachgebiet Chirurgie

Verbände und Cremes gegen Dekubitus: „Wir wissen nicht, was sie bringen!“

Die Datenlage zur Wirksamkeit von Verbänden oder topischen Mitteln zur Prävention von Druckgeschwüren sei schlecht, so die Verfasser einer aktuellen Cochrane-Studie. Letztlich bleibe es unsicher, ob solche Maßnahmen den Betroffenen nutzen oder schaden.

Nackenschmerzen nach Bandscheibenvorfall: Muskeltraining hilft!

Bei hartnäckigen Schmerzen aufgrund einer zervikalen Radikulopathie schlägt ein Team der Universität Istanbul vor, lokale Steroidinjektionen mit einem speziellen Trainingsprogramm zur Stabilisierung der Nackenmuskulatur zu kombinieren.

US-Team empfiehlt Gastropexie nach Hiatushernien-Op.

Zur Vermeidung von Rezidiven nach Reparatur einer paraösophagealen Hiatushernie sollte einem US-Team zufolge der Magen bei der Op. routinemäßig an der Bauchwand fixiert werden. Das Ergebnis einer randomisierten Studie scheint dafür zu sprechen.

Mit Lidocain kommt der Darm nicht schneller in Schwung

Verzögertes Wiederanspringen der Darmfunktion ist ein Hauptfaktor dafür, wenn Patientinnen und Patienten nach einer Kolonresektion länger als geplant im Krankenhaus bleiben müssen. Ob man diesem Problem mit Lidocain vorbeugen kann, war Thema einer Studie.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.